-
Differentially expressed proteins in glioblastoma multiforme identified with a nanobody-based anti-proteome approach and confirmed by OncoFinder as possible tumor-class predictive biomarker candidates [Elektronski vir]Jovchevska, Ivana ...Glioblastoma multiforme is the most frequent primary malignancy of the central nervous system. Despite remarkable progress towards an understanding of tumor biology, there is no efficient treatment ... and patient outcome remains poor. Here, we present a unique anti-proteomic approach for selection of nanobodies specific for overexpressed glioblastoma proteins. A phage-displayed nanobody library was enriched in protein extracts from NCH644 and NCH421K glioblastoma cell lines. Differential ELISA screenings revealed seven nanobodies that target the following antigens: the ACTB/NUCL complex, VIM, NAP1L1, TUFM, DPYSL2, CRMP1, and ALYREF. Western blots showed highest protein up-regulation for ALYREF, CRMP1, and VIM. Moreover, bioinformatic analysis with the OncoFinder software against the complete "Cancer Genome Atlas" brain tumor gene expression dataset suggests the involvement of different proteins in the WNT and ATM pathways, and in Aurora B, Sem3A, and E-cadherin signaling. We demonstrate the potential use of NAP1L1, NUCL, CRMP1, ACTB, and VIM for differentiation between glioblastoma and lower grade gliomas, with DPYSL2 as a promising "glioma versus reference" biomarker. A small scale validation study confirmed significant changes in mRNA expression levels of VIM, DPYSL2, ACTB and TRIM28. This work helps to fill the information gap in this field by defining novel differences in biochemical profiles between gliomas and reference samples. Thus, selected genes can be used to distinguish glioblastoma from lower grade gliomas, and from reference samples. These findings should be valuable for glioblastoma patients once they are validated on a larger sample size.Source: Oncotarget [Elektronski vir]. - ISSN 1949-2553 (Vol. 8, no. 27, Jul. 2017, str. 44141-44158)Type of material - e-article ; adult, seriousPublish date - 2017Language - englishCOBISS.SI-ID - 33233113
Author
Jovchevska, Ivana |
Šamec, Neja, 1983- |
Urlep, Žiga |
Vranič, Andrej |
Matos, Boštjan |
Limbaeck Stanic, Clara |
Muyldermans, Serge |
Myers, Michael P. |
Buzdin, Anton A. |
Petrov, Ivan |
Komel, Radovan
Topics
glioblastoma multiforme |
biomarkers |
nanobodies |
multiformni glioblastom |
označevalci |
nanotelesa
![loading ... loading ...](themes/default/img/ajax-loading.gif)
Shelf entry
Permalink
- URL:
Impact factor
Access to the JCR database is permitted only to users from Slovenia. Your current IP address is not on the list of IP addresses with access permission, and authentication with the relevant AAI accout is required.
Year | Impact factor | Edition | Category | Classification | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Select the library membership card:
DRS, in which the journal is indexed
Database name | Field | Year |
---|
Links to authors' personal bibliographies | Links to information on researchers in the SICRIS system |
---|---|
Jovchevska, Ivana | 38279 |
Šamec, Neja, 1983- | 33735 |
Urlep, Žiga | 35357 |
Vranič, Andrej | 18471 |
Matos, Boštjan | 20251 |
Limbaeck Stanic, Clara | 34893 |
Muyldermans, Serge | ![]() |
Myers, Michael P. | ![]() |
Buzdin, Anton A. | ![]() |
Petrov, Ivan | ![]() |
Komel, Radovan | 06135 |
Select pickup location:
Material pickup by post
Notification
Subject headings in COBISS General List of Subject Headings
Select pickup location
Pickup location | Material status | Reservation |
---|
Please wait a moment.